(Q39321860)

English

Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

author name string

C Z Cotrim

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

V Fabris

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

M L Doria

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

K Lindberg

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

J-Å Gustafsson

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

F Amado

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

C Lanari

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

L A Helguero

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

2 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

2390-2402

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

https://scigraph.springernature.com/pub.10.1038/onc.2012.261

0 references

The genome landscape of ERalpha- and ERbeta-binding DNA regions

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Biological determinants of endocrine resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

ER beta inhibits proliferation and invasion of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

The potential role of ER beta isoforms in the clinical management of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Challenging estrogen receptor beta with phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Paracrine-acting adiponectin promotes mammary epithelial differentiation and synergizes with genistein to enhance transcriptional response to estrogen receptor β signaling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Induction of apoptosis in HeLa cells by trans-activation-deficient p53.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Transcription-independent pro-apoptotic functions of p53.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Breast cancer models to study the expression of estrogen receptors with small animal PET imaging.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Crosstalk between EGFR and extranuclear steroid receptors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Cracking the estrogen receptor's posttranslational code in breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Soy food intake and breast cancer survival

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptors: therapies targeted to receptor subtypes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen signaling: a subtle balance between ER alpha and ER beta

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Genistein action in the prepubertal mammary gland in a chemoprevention model

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Estrogen receptor knockout mice as a model for endocrine research

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.261

31 March 2020

Identifiers

10.1038/ONC.2012.261

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Dimensions Publication ID

0 references

release_pouoa3mvcvafxe66pipvsozc5m

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39321860&oldid=1820011420"